secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANGAMO THERAPEUTICS, INC (SGMO)
CIK:        0001001233
Form:       8-K
Filed at:   2024-10-04T23:59:59+00:00
Accession:  0001628280-24-042308
Event type: litigation
Sentiment:  negative
Materiality: 0.70
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sangamo files to validate share increase; stockholder challenge; hearing Dec 12
-------------------------------------------------------------------------------

- Stockholder lawsuit claims wrong voting standard for share increase; company seeks validation.
- Sangamo filed Section 205 petition to validate amendment increasing authorized shares from 640M to 960M.
- Vote results: 107.95M for (52% of outstanding, 92% of votes cast); both standards met.
- Court of Chancery hearing scheduled Dec 12, 2024; opposition due Nov 12.
- Company previously warned of going concern risk; validation needed to enable equity fundraising.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1001233/000162828024042308/0001628280-24-042308-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1001233/000162828024042308/sgmo-20241004.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-042308

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer